Global Regenerative Medicine Markets, 2015-2025 - Impact of COVID-19, Trends & Developments, Competitive Landscape - ResearchAndMarkets.com

The "Global Regenerative Medicine Market By Therapy (Cell-Based Immunotherapy & Cell Therapy, Gene Therapy, Others), By Application, By Material, By Cell, By Product, By Technique, By Distribution Channel, By Region, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.

The Global Regenerative Medicine Market is expected to register a double digit CAGR through 2025 owing to their increasing use in repair, replacement or regeneration of cells, tissues and organs. Additionally, high prevalence of chronic & genetic dieses, emergence of stem cell technology and growing aging populations are some of the key factors driving the regenerative medicine market.

Regenerative medicines deal with process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function. They are also being used to create solutions for organs that become permanently damaged. These medicines are also used in treatment of some uncurable dieses like arthritis and diabetes.

Increasing number of cancer patients, neurodegenerative, orthopedic, and other aging-associated disorders is creating a significant demand for the regenerative medicine market globally. Various countries like United States, China and Japan are investing in stem cell research, which indicates a bright future for regenerative medicine manufacturers.

The Global Regenerative Medicine Market also faces some restraints like high treatment costs, stringent government regulations and operative inefficiency. High investment required for developing the medicine might also limit the market growth.

The market is segmented based on therapy, application, material, cell, product, technique, distribution channel and region. The application segment comprises of musculoskeletal disorders, wound care, oncology, neurology, ocular disorders, diabetes, cardiology and others. Out of them, the musculoskeletal segment is expected to dominate the market during the forecast years owing to growing use of regenerative medicines for treating musculoskeletal disorders and increasing number of orthopedic diseases.

Based on material, the regenerative medicine market is segmented into synthetic material, biologically derived material, genetically engineered material and pharmaceutical. The biologically derived material dominated the regenerative medicine market in 2019 and is expected to further hold its position in the coming years due to its unique properties. This type of material promotes cellular interactions, increases proliferation and controls the manipulation of cellular behavior.

Major players operating in the Global Regenerative Medicine Market include Novartis AG, Vericel, Integra Lifesciences, Mimedx Group, Stryker, Wright Medical, Roche, Bristol-Myers Squibb, Allergan, Corline Biomedical, Cook Biotech, Pfizer, Baxter, Boehringer Ingelheim, Caladrius Biosciences, Takara Bio, Medtronic, Osiris Therapeutics, Kite Pharma, Organogenesis and others. Due to growing demand from Asia-Pacific region, the manufacturers are focusing on countries like India and China where geriatric population is increasing rapidly.

Years considered for this report:

• Historical Years: 2015-2018
• Base Year: 2019
• Estimated Year: 2020
• Forecast Period: 2021-2025

Objective of the Study

• To analyze and forecast the market size of the Global Regenerative Medicine Market.
• To classify and forecast the Global Regenerative Medicine Market based on therapy, application, material, cell, product, technique, distribution channel and regional distribution.
• To identify drivers and challenges for the Global Regenerative Medicine Market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Regenerative Medicine Market.
• To conduct pricing analysis for the Global Regenerative Medicine Market.
• To identify and analyze the profile of leading players operating in the Global Regenerative Medicine Market.

Key Topics Covered

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Regenerative Medicine Market

4. Executive Summary

5. Voice of Customer

6. Global Regenerative Medicine Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value & Volume

6.2. Market Share & Forecast

6.2.1. By Therapy (Cell-Based Immunotherapy & Cell Therapy, Gene Therapy, Tissue-Engineering, Immunomodulation therapy, Blood transfusion, Bone marrow transplantation, Plasma rich plasma therapy, Prolotherapy, Others)

6.2.2. By Application (Musculoskeletal Disorders, Wound Care, Oncology, Neurology, Ocular Disorders, Diabetes, Cardiology, Others)

6.2.3. By Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, Pharmaceutical)

6.2.3.1. By Synthetic Material (Biodegradable Synthetic Polymers, Scaffold, Artificial Vascular Graft Materials, Hydrogel Materials)

6.2.3.2. By Biologically Derived Material (Collagen, Xenogeneic Material)

6.2.3.3. By Genetically Engineered Material (Genetically Manipulated Cells, 3D Polymer Technology, Transgenic, Fibroblast, Neural Stem Cells, Gene-activated Matrices)

6.2.3.4. By Pharmaceutical (Small Molecules, Biologics)

6.2.4. By Cell (Autologous, Allogenic)

6.2.5. By Product (Biologic, Cell -based Medical Devices, Biopharmaceutical, Biomaterial)

6.2.6. By Technique (Microfracture, Mosaicplasty)

6.2.7. By Distribution Channel (Hospitals, Clinics, Online, Others)

6.2.8. By Region

6.2.9. By Company

7. North America Regenerative Medicine Market Outlook

8. Europe Regenerative Medicine Market Outlook

9. Asia-Pacific Regenerative Medicine Market Outlook

10. Middle East & Africa Printing Ink Market Outlook

11. South America Regenerative Medicine Market Outlook

12. Market Dynamics

12.1. Drivers

12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

14.1. Competition Outlook

14.2. Company Profiles

14.2.1. Novartis AG

14.2.2. Vericel

14.2.3. Integra Lifesciences

14.2.4. Mimedx Group

14.2.5. Stryker

14.2.6. Wright Medical

14.2.7. Roche

14.2.8. Bristol-Myers Squibb

14.2.9. Allergan

14.2.10. Corline Biomedical

14.2.11. Cook Biotech

14.2.12. Pfizer

14.2.13. Baxter

14.2.14. Boehringer Ingelheim

14.2.15. Caladrius Biosciences

14.2.16. Takara Bio

14.2.17. Medtronic

14.2.18. Osiris Therapeutics

14.2.19. Kite Pharma

14.2.20. Organogenesis

15. Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/1e9aff

View source version on businesswire.com: https://www.businesswire.com/news/home/20200514005384/en/